Light therapy before surgery for cervical precancer
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a high-grade cervical precancerous lesion (CIN2 or CIN3) confirmed by biopsy within the last 3 months.
- Your doctor can see the entire affected area during a colposcopy exam.
- You are not pregnant and are willing to use contraception during the study.
- You have not had prior surgical treatment on your cervix that changed its shape.
- You do not have certain infections, immune conditions, or allergies that would make the treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study is testing a new, non-invasive way to screen for cervical cancer using light-based detection and epigenetic analysis. It may help find high-risk changes earlier and more accurately than current methods.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.